Citation Impact
Citing Papers
A genomic region associated with protection against severe COVID-19 is inherited from Neandertals
2021 StandoutNobel
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
The Oligoadenylate Synthetase Family: An Ancient Protein Family with Multiple Antiviral Activities
2010
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Global Genetic Variation at OAS1 Provides Evidence of Archaic Admixture in Melanesian Populations
2012
Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases
2015
Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation.
1983
Hepatocellular carcinoma
2003 Standout
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach
2001
Primary Biliary Cirrhosis
2005
Inflammation and cancer
2002 StandoutNature
Natural history of hepatitis B
2003
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Variation in Antiviral 2′,5′-Oligoadenylate Synthetase (2′5′AS) Enzyme Activity Is Controlled by a Single-Nucleotide Polymorphism at a Splice-Acceptor Site in the OAS1 Gene
2005
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Characteristics of hepatocellular carcinoma in Italy
1998
cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING
2013 StandoutNature
Hepatocellular carcinoma
2018 Standout
Hepatitis C Virus Infection
2001 Standout
Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma
1994
Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial
1998
Tamoxifen Does Not Improve Survival of Patients With Advanced Hepatocellular Carcinoma
1998
Epidemiological characteristics and risk factors of hepatocellular carcinoma
1997
Global Cancer Statistics, 2002
2005 Standout
Renal sodium retention in cirrhosis: Tubular site and relation to hepatic dysfunction
1988
Ulcerative Colitis
2011 Standout
Rising Incidence of Hepatocellular Carcinoma in the United States
1999 Standout
High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial
2002
Long–Term Suppression of Hepatitis B E Antigen–Negative Chronic Hepatitis B by 24–Month Interferon Therapy
2003
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival
2010
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
1988 Standout
Systematic review: the costs of ulcerative colitis in Western countries
2010
Screening for hepatocellular carcinoma
1998
Efficacy of Oral vs. Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Meta-Analysis
2011
Hepatocellular carcinoma
2012 Standout
Long interval between HCV infection and development of hepatocellular carcinoma
1995
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 Standout
Hepatitis B virus infection
2009 Standout
A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma
1998
Long-Term Course of Chronic Hepatitis C in Children: From Viral Clearance to End-Stage Liver Disease
2008
Silencing of USP18 Potentiates the Antiviral Activity of Interferon Against Hepatitis C Virus Infection
2006 StandoutNobel
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Epidemiology of hepatitis C
1997 Standout
Screening for Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis: A Cost-Utility Analysis
2003
The changing epidemiology of hepatitis C virus infection in Europe
2007
Management of Hepatocellular Carcinoma *
2005 Standout
Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
1997
Global cancer statistics
2011 Standout
Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man
2009
Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis
1996
Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study
2006
Ulcerative colitis
2012 Standout
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Epidemiology of hepatitis C
1996
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy
2010
Estrogen Receptors in Human Nontarget Tissues: Biological and Clinical Implications*
1995
Chronic hepatitis B
2007 Standout
Treatment of hepatocellular carcinoma in patients with cirrhosis
1997
Hepatitis C Virus: Epidemiology, Transmission and Prevention
1998
Chronic hepatitis B: Update 2009 #
2009 Standout
Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study
2000
Analysis of a Successful Immune Response against Hepatitis C Virus
1999 StandoutNobel
Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors
2001
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
Loco‐regional treatment of hepatocellular carcinoma†
2010
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
2002 Standout
Ulcerative colitis
2016 Standout
Hepatic Gene Expression Discriminates Responders and Nonresponders in Treatment of Chronic Hepatitis C Viral Infection
2005
Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy
2003
Inflammation and the development of pancreatic cancer
2002
Hepatitis C virus infection in households of anti-HCV chronic carriers in Italy: A multicentre case-control study
1997
Obesity and the Risk of Heart Failure
2002 Standout
Use and misuse of population attributable fractions.
1998
Sex hormone receptors in hepatocellular carcinoma
1993
Molecular basis of agonism and antagonism in the oestrogen receptor
1997 StandoutNature
The global impact of vaccination against hepatitis B: A historical overview
2008
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
2012
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
Viruses and hepatocellular carcinoma.
1994
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Global burden of blood-pressure-related disease, 2001
2008 Standout
Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy
2012 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients
1995
Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern Italy
1997
Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer?
1997
Hepatocellular Carcinoma
2011 Standout
Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes
1997
Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection
2016 StandoutNatureNobel
Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis
2002
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 Standout
Interferon-inducible antiviral effectors
2008 Standout
Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis
2001
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis
1999
Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study
1994
Type of estrogen receptor determines response to antiestrogen therapy.
1996
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
2016
Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites: An overview with emphasis on pathogenesis
1986
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus–related cirrhosis
2001
Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: A randomized, controlled trial
1995
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Risk of liver and other types of cancer in patients with cirrhosis: A nationwide cohort study in Denmark
1998
Review article: overview of medical treatments in unresectable hepatocellular carcinoma—an impossible meta‐analysis?
1998
Surveillance for hepatocellular carcinoma
2014
Intrahepatic cholestasis of pregnancy
2009
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Sex hormone receptors in hepatocellular carcinoma (HCC). Is there a rationale for hormonal treatment?
1991
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
Hepatitis C virus genotypes: An investigation of type-specific differences in geographic origin and disease
1994
Aquaporins in the Kidney: From Molecules to Medicine
2002 StandoutNobel
Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support.
1994
Hepatocellular carcinoma complicating autoimmune hepatitis: Role of hepatitis C virus
1995
High prevalence of hepatitis C virus infection in patients with B‐cell lymphoproliferative disorders in Italy
1997
Works of M. Chiaramonte being referenced
Baseline sero-epidemiology of hepatitis B virus infection in children and teenagers in Italy. A survey before mass hepatitis B vaccination
1991
Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR
2003
Chronic hepatitis D: A vanishing disease? An Italian multicenter study
2000
Anti-HCV positive hepatocellular carcinoma in cirrhosis
1992
Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen
1990
Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy
1996
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy
1994
Multicentre randomized placebo‐controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis
2000
Interferon treatment in hepatitis B surface antigen‐positive hepatitis B e antibody‐positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring
1998
Anti-Hepatitis C Virus in the Elderly: A Seroepidemiological Study in a Home for the Aged
1992
Hepatocellular carcinoma in primary biliary cirrhosis
1994
Low prevalence of anti-HCV antibody among Italian children
1994
Impact of evidence‐based medicine on the treatment of patients with unresectable hepatocellular carcinoma
2009
Hepatitis C virus infection in pregnancy
1996
Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis
2004
HBV and HCV infection among non-European Union immigrants in North-East Italy
1998
Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma
1992
Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma
1992
Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
1998
Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study (a report from the HCV study group of the Italian Association for the Study of the Liver).
1991
Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC).
1994
Renal Handling Of Sodium and Water in Early Chronic Liver Disease
1981